Cardiopulmonary Bypass Equipment Market Analysis & Forecast: 2025-2032

Cardiopulmonary Bypass Equipment Market Analysis & Forecast: 2025-2032

Cardiopulmonary Bypass Equipment Market is estimated to be valued at USD 210.9 Mn in 2025 and is expected to reach USD 256.0 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 2.8% from 2025 to 2032.

To learn more about this report, Download Free Sample

Key Takeaways

• Based on Product Type, the Single Roller Pump is the most popular segment and is predicted to hold the largest market share of 60.6% in 2025. This is due to cardiac surgeons have long used it and it is more affordable than other pump designs.
• Based on End-User, Hospitals Segment is estimated to contribute the second highest market share of 40.12% in 2025 due to substantial case volume that is handled within hospital settings.
• Based on region, North America has been leading the global cardiopulmonary bypass equipment market, accounting for over 40.7% of total transplants worldwide in 2025. The region's dominance is attributed to its advanced transplant centers, supportive reimbursement policies, and increasing awareness.  

Market Overview

Global cardiopulmonary bypass equipment market is expected to witness a steady growth over the forecast period due to increasing prevalence of cardiovascular diseases and growing demand for minimally invasive surgeries. Moreover, advancement in clinical research for improving bypass equipment and rising healthcare expenditure can also drive the market growth during this period. However, high costs associated with cardiopulmonary bypass surgeries and lack of awareness in developing regions are expected to hinder the market growth.   

For instance, in October 2024, Prime Minister of India virtually inaugurated new facilities at AIIMS-Kalyani in North 24 Parganas district of West Bengal, which includes a cardiac laboratory and a generic medicine outlet. The cardiac Cath laboratory has imaging equipment to visualize the heart’s chamber’s arteries and other parts, while a new cardiopulmonary bypass (CPB) machine can temporarily take over the functions of the heart and lungs during a surgery.

Current Events and Its Impact on the Cardiopulmonary Bypass Equipment Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Cardiopulmonary Bypass Equipment Market Insights, by Product Type: Single Roller Segment domaintes due to Strong Demand for Ferrous Metal Castings in Core Industrial Sectors

By Product Type, Single Roller Pump Segment is estimated to account for the highest market share of 60.6% in 2025 because cardiac surgeons have been using it for a long time and because it is more affordable than other pump designs. For the majority of operations, the single roller pump is the preferred option as it was one of the first pump designs created for cardiopulmonary bypass treatments. Surgeons can utilize it with ease due to its straightforward roller based.

Compared to more intricate multi-roller pumps, the design of a single roller pump results in lower production and cardiopulmonary bypass equipment maintenance procedures costs. Healthcare establishments can now afford single roller pumps due to this cost advantage.

For instance, in February 2025, Ellesmere Town Council is thrilled to announce the launch of a crowdfunding campaign aimed at building a pump track in the town, at Berwyn View. This innovative project, designed to provide a safe and fun environment for riders of all ages and skill levels, will promote active lifestyles, enhance community engagement, and support local youth. The pump track will feature a series of rollers, berms, and jumps, allowing cyclists, skateboarders, and scooter riders to build skills and have fun in a controlled setting.

Cardiopulmonary Bypass Equipment Market Insights, by End User: Hospital Division is boosted by High Prevalence and Mortality Rates

Among end user, hospitals segment is estimated to contribute the highest market  share of 40.12% in 2025 due to a significant number of cases are managed in hospital settings. Hospitals perform the most cardiopulmonary bypass surgeries annually because they are the default caregivers for life-threatening illnesses like cardiovascular disease. Hospitals will very certainly have the greatest need for cardiopulmonary bypass equipment due to the size of their cardiac programs. Another benefit hospitals possess is established infrastructure for complex surgeries. Operating rooms, specialist staff, and postoperative care units allow hospitals to comfortably accommodate cardiopulmonary bypass procedures. Resources for equipment purchase and maintenance are also more readily available to hospitals as compared to other end users.

As large urban hospitals, in particular, have sizable capital budgets, purchasing high-end cardiopulmonary bypass devices is an affordable investment. Long-term support for follow-up service agreements is also possible. Hospitals are viewed by equipment makers as a low risk customer sector that is less susceptible to financial limitations. Consequently, cardiopulmonary bypass equipment manufacturers give hospital customers specific needs top priority, solidifying their position as industry leaders.

For instance, in June 2024, A new, robotic approach to heart bypass surgery is now being offered to patients at University Hospitals (UH) with great success. Two UH Harrington Heart & Vascular Institute providers, are currently the only surgeons in Ohio performing this specific type of procedure using the Da Vinci surgical robot. This robot assists surgeons in performing coronary artery bypass grafting (CABG) through a minimally invasive approach which leaves patients with less pain and a shorter recovery after surgery.

Regional Insights

To learn more about this report, Download Free Sample

North America Cardiopulmonary Bypass Equipment Market Analysis and Trends

North America has been leading the cardiopulmonary bypass equipment market, accounting for over 40.7% of total transplants worldwide last year. Its cutting edge transplant facilities, encouraging reimbursement practices, and growing awareness are the reasons for the region’s dominance. The market in the U.S. alone is twice as large as that of any other nation. North American medical device businesses make significant investments in R&D to ensure ongoing innovation in organ.

For instance, in September 2024, Vesalio, a privately held medical device company focused on advancing patient care in vascular diseases has announced the U.S. commercialization of its pVasc Thrombectomy System. The mechanical device is designed for the non-surgical removal of peripheral occlusions, which are blockages in the arteries of the arms and legs caused by blood clots, inflammation, and narrowing blood vessels.

Asia Pacific Cardiopulmonary Bypass Equipment Market Analysis and Trends

Asia Pacific has emerged as the fastest-growing market due to rising chronic kidney disease incidences, growing incomes, and government initiatives to boost organ donation. Transplants have increased, especially in China, as a result of initiatives to improve local production, alter donation regulations, and lower costs. Due to the region’s promising growth prospects, this has drawn international medical technology companies to invest in partnerships and local manufacturing in China.

For instance, in April 2024, the civic-run KEM Hospital in Parel is poised to start its heart transplant programme, as its cardiac surgery department has enrolled two patients for heart transplants. The hospital will become the first public hospital in the state to offer this programme by securing the license to conduct heart transplants.

Europe Cardiopulmonary Bypass Equipment Market Analysis and Trends

The European cardiopulmonary bypass accessor equipment industry growth is driven by the increasing prevalence of cardiovascular diseases, a growing geriatric population, and ongoing technological advancements in bypass equipment. Major product categories include oxygenators, ECMO machines, pumps, cannula, temperature monitors, and various accessories. The adult patient segment dominates the market which reflects the high incidence of cardiac disease in this demographic.

Cardiopulmonary Bypass Equipment Market Dominating Countries

U.S Cardiopulmonary Bypass Equipment Market Analysis and Trends

The U.S. cardiopulmonary bypass (CPB) equipment market is experiencing significant growth which is driven by technological advancements, a rising prevalence of cardiovascular diseases, and an increasing demand for minimally invasive surgical procedures. Innovations such as compact and portable CPB machines, improved oxygenators, and integration with digital monitoring systems have enhanced the safety and efficiency of cardiac surgeries.      

India Cardiopulmonary Bypass Equipment Market Analysis and Trends

India faces a significant burden of cardiovascular diseases, including heart attacks and strokes due to factors like obesity, diabetes, and lifestyle changes. The adoption of minimally invasive surgical (MIS) procedures is increasing, offering benefits such as reduced postoperative pain and faster recovery times.

China Cardiopulmonary Bypass Equipment Market Analysis and Trends

China is aggressively incentivizing local production to reduce dependence on imports and improve accessibility in secondary cities. Increasing across the country, with a rise in procedures such as CABG (coronary artery bypass grafting) and value replacements. CPB systems are incorporating real-time monitoring, data analytics, and AI for better intraoperative decision-making.

Market Concentration and Competitive Landscape

To learn more about this report, Download Free Sample

Cardiopulmonary Bypass Equipment Market Growth Drivers

Rising Burden of Cardiovascular Diseases

• Rising prevalence of cardiovascular diseases across the world can boost demand for cardiopulmonary bypass equipment. Cardiovascular diseases are the leading causes of mortality worldwide.
• According to the data published by the World Health Organization, cardiovascular diseases is estimated to grow to over 23 million by 2030. Growing geriatric population base can increase the risk of various heart conditions.
• Moreover, changing lifestyles and increasing consumption of unhealthy diets have also contributed to rising incidence of diseases like coronary artery disease and heart failure. This has significantly boosted the number of open-heart surgeries and other cardiac procedures performed annually. Cardiopulmonary bypass is essential for most of these surgical interventions.
• The World Heart Report, released at the 2023 World Heart Summit, offers the first comprehensive analysis of CVD risk and mortality data globally, thus, highlighting significant regional disparities. Despite an overall increase in CVD deaths over the past three decades, the global CVD death rate had decreased from 354.5 to 239.9 deaths per 100,000 people, with high-income countries experiencing the most rapid decline.

Technological Advancements

• Constant technological advancements can boost demand for cardiopulmonary bypass equipment. Vendors are continually focusing on developing novel product ranges with added features to improve therapeutic outcomes.
• For instance, new cardiopulmonary bypass machines feature miniaturized components for minimal invasiveness. Advanced bubble oxygenators enables homogeneous gas transfer without affecting blood flow regulation. Next-generation heart-lung machines are outfitted with enhanced safety alarms and automated regulatory mechanisms. Such innovations allow for more efficient and controlled CBP procedures.
• The introduction of affordable equipment variants increases access in price-sensitive low and middle-income markets. The integration of virtual technologies like artificial intelligence and machine learning improves intra-operative decision making and reduce manual errors. Rising investments by players towards R&D of more innovative solutions can offer new growth opportunities.

Cardiopulmonary Bypass Equipment Market: Trends

• Focus on Neuroprotection and Patient Safety: There is increasing concern over neurological complications post CPB surgeries for example, stroke, cognitive decline. New systems include cerebral oximetry, automated temperature control and ultrafiltration to reduce inflammatory responses and emboli.
• For instance, in April 2024, WHO launched a Patient Safety Rights Charter at the Global Ministerial Summit on Patient Safety. It is the first Charter to outline patients’ rights in the context of safety, and will support stakeholders in formulating the legislation, policies and guidelines needed to ensure patient safety. Patient safety refers to the processes, procedures and cultures established in health systems which promote safety and minimise the risk of harm to patients.

• Biocompatible & Advance Coatings: Manufactuers are investing in heparin-bonded and biocompatible coatings on CPB circuits to reduce; platlet activatio, coagulopathies, and postoperative inflammation.

• Shift Toward Minimally Invasive and Outpatient Procedures: There’s a growing trend toward minimally invasive coronary artery bypass grafting (CABG), requiring specialized CPB equipment. The adoption of minimally invasive procedures has led to more surgeries being performed in outpatient settings, reducing hospitalization times and costs.
• For instance, in April 2025, JLL has tapped Executive Managing Director Brannan Moss to lead a new healthcare hub designed to help clients optimize their medical property portfolios and win more business in the sector as demand for outpatient services continues to increase. The real estate services firm, the world's second largest behind CBRE based on revenue, said its new JLL Healthcare Center of Excellence will provide resources and expertise to the group’s health system and healthcare provider clients nationally, comprising healthcare professionals within JLL’s leasing advisory business.

Market Report Scope

Cardiopulmonary Bypass Equipment Market: Key Developments

• June 2024, Royal Philips, a global leader in health technology, announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
• June 2024, AliveCor, the global leader in AI-powered cardiology, announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of KAI™ 12L AI technology and the Kardia™ 12L ECG System. This is the world’s first AI that can detect life-threatening cardiac conditions, including heart attacks, using a reduced leadset.
• May 2024, iHridAI, a Bengaluru-based healthcare technology startup focused on developing globally benchmarked and viable technology solutions for healthcare diagnostics, launched its flagship product, HarmonyCVI, for detailed and accurate cardiovascular assessments. HarmonyCVI is a comprehensive artificial intelligence (AI)/ machine learning (ML)-based rapid diagnostics and insights tool that aids cardiologists and radiologists in enhanced analysis of cardiac MRI scans.
• March 2024, Stryker, a global leader in medical technologies, participated at the Criticare National Conference (2024), held from March 1st to 3rd at the ITC Royal Bengal in Kolkata, India. During the event, Stryker launched and showcased two new products – “LIFEPAK CR2 automated external defibrillator (AED) for cardiac care” and “Evacuation Chair” for emergency patient evacuation. 

• May 2023, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to London-based LivaNova for its Essenz Heart-Lung Machine (HLM), designed for use in cardiopulmonary bypass (CPB) procedures. This approval allows LivaNova to begin the commercial rollout of the Essenz system in the United States.

Analyst Opinion

• Global cardiopulmonary bypass equipment market growth is driven by rising prevalence of cardiovascular diseases worldwide. Growing geriatric population who are more prone to heart conditions can boost demand for cardiopulmonary bypass surgeries and equipment. Increasing investments by both public and private players to enhance healthcare infrastructure and encourage cardiac surgeries in developing nations can offer opportunities for market players.
• High costs associated with bypass equipment and surgeries can hamper the market growth. The lack of reimbursement policies and limited accessibility to healthcare in low-income countries can also hamper the market growth. Stringent regulatory approvals for new product launches pose another challenge for manufacturers.
• North America dominates the cardiopulmonary bypass equipment market due to robust healthcare infrastructure and rising healthcare expenditure in the region. Asia Pacific is likely to witness the fastest growth due to improving access to healthcare and rising medical tourism across developing countries like India and China.

Market Segmentation

• By Product Type
  
  • Single Roller Pump
  • Double Roller Pump
• By End User
  
  • Hospitals
  • Ambulatory Surgical Centres 
  • Others
    
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Company Profiles
  • Medtronic
  • LivaNova (formerly Sorin Group)
  • Terumo Cardiovascular Systems Corporation
  • Maquet Holding BV & Co. KG
  • Braun Melsungen AG
  • Medica s.p.a.
  • Eurosets
  • Fresenius Medical Care AG & Co. KGaA
  • Lepu Medical Technology
  • Elite Life Care
  • OriGen Biomedical
  • Tianjin Medical
  • Soma Technology, Inc.
  • Braile Biomedica
  • CardioGenesis Corporation 
  • Century Medical, Inc.
  • Nonin Medical, Inc.
  • Xijian Medical

Sources

Primary Research interviews

• Cardiac Surgeons / Perfusionists, Procurement Heads / Biomedical Engineers, Medical Device Distributors & Importers, Regulatory Experts, Product Manager.

Databases:

• AlphaSense

Magazines:

• Cambridge University Press, DelveInsight, Anesthesia & Analgesia, NCBI Bookshelf.

Journals:

• Journal of Cardiothoracic and Vascular Anesthesia, Annals of Thoracic Surgery, Journal of ExtraCorporeal Technology, European Journal of Cardio-Thoracic Surgery.

Newspapers:

• The New York Times, Reuters Health, Bloomberg.

Associations:

• World Health Organization (WHO), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), American Heart Association (AHA), European Association for Cardio-Thoracic Surgery (EACTS).

Proprietary Elements:

• CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 8 years

*Definition: Cardiopulmonary bypass equipment-commonly known as a heart-lung machine-is a medical device used during certain surgeries to temporarily take over the function of the heart and lungs. It diverts blood away from the heart and lungs, oxygenates and removes carbon dioxide from the blood, and then pumps the oxygen-rich blood back into the body, ensuring continuous circulation and oxygen delivery during procedures like open-heart surgery.